Predictors of post-ERCP complications in patients with suspected choledocholithiasis

被引:103
|
作者
Mehta, SN
Pavone, E
Barkun, JS
Bouchard, S
Barkun, AN
机构
[1] McGill Univ, Montreal Gen Hosp, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Montreal Gen Hosp, Div Gen Surg, Montreal, PQ H3G 1A4, Canada
[3] McGill Univ, Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1055/s-2007-1001308
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Study Aims: Determinants of complications after endoscopic retrograde cholangiopancreatography (ERCP) have not yet been completely characterized, Patients and Methods: Data were collected from an endoscopic database. Univariate analysis and multivariate logistic regression analysis were used to generate the best model of independent predictors of post-ERCP pancreatitis, Results: The database included 1239 ERCP examinations carried out to investigate suspected choledocholithiasis over a five-year period. From these, 45 patients who developed post-ERCP complications were compared to a random sample of 486 patients who had undergone an uncomplicated ERCP for suspected choledocholithiasis, Univariate analysis demonstrated significant differences between the two patient groups for the following factors: age, using a cut-off point of 59 years (27% vs. 51%, P = 0.002), pancreatic channel opacification (73% vs. 58%, P = 0.05), and absence of common bile duct stones (41% vs. 24%, P = 0.03), Using multivariate logistic regression, the best model for predicting post-ERCP pancreatitis in patients undergoing sphincterotomy included age under 59 years (P = 0.04), and absence of a common bile duct stone (P = 0.004), The model yielded probabilities of developing post-sphincterotomy pancreatitis that ranged from 2.8% if no predictor was present, to 27% when both predictors were present. Among patients in whom a sphincterotomy was not performed, the only significant independent predictor found was pancreatic channel opacification (P = 0,05), Conclusion: Age under 59 years, pancreatic channel opacification, and an absence of common bile duct stones at ERCP are all independent predictors of post-ERCP pancreatitis.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 50 条
  • [31] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    [J]. GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [32] Comparative Risks of Post-ERCP Adverse Events in Patients with Asymptomatic and Symptomatic Choledocholithiasis: A Systematic Review and Meta-Analysis
    Obaitan, Itegbemie
    Mohamed, Mouhand F. H.
    Beran, Azizullah
    Rosenheck, Michael
    Obomanu, Elvis T.
    Berzin, Tyler M.
    Ramai, Daryl
    Wehbe, Hisham
    Aziz, Muhammad
    Mahendraker, Neetu
    Al-Haddad, Mohammad
    Easler, Jeffrey J.
    Fogel, Evan L.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1880 - 1888
  • [33] Malnutrition and Post-ERCP Complications: Nationwide Inpatient Sample Database Analysis
    Manoharan, Anjella
    Wong, Vincent
    Panchal, Dayna
    Wang, Weizheng
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S829 - S829
  • [34] Clinical Outcomes and Predictors of Severity of Post-ERCP Pancreatitis - A Nationwide Analysis
    Abbas, Ali
    Sethi, Sajiv
    Vidyarthi, Gitanjali
    Taunk, Pushpak
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S35 - S36
  • [35] Somatostatin (SS) and gabexate (GM) are ineffective in preventing post-ERCP complications
    Andriulli, A
    Solmi, L
    Loperfido, S
    Festa, V
    Belmonte, A
    Leo, P
    Spirito, F
    Silla, M
    Forte, G
    Terruzzi, V
    Mescia, P
    Ciliberto, E
    Maglia, M
    Monica, F
    Perri, F
    [J]. GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB106 - AB106
  • [36] Comparative Risks of Post-ERCP Adverse Events in Patients with Asymptomatic and Symptomatic Choledocholithiasis: A Systematic Review and Meta-Analysis
    Itegbemie Obaitan
    Mouhand F. H. Mohamed
    Azizullah Beran
    Michael Rosenheck
    Elvis T. Obomanu
    Tyler M. Berzin
    Daryl Ramai
    Hisham Wehbe
    Muhammad Aziz
    Neetu Mahendraker
    Mohammad Al-Haddad
    Jeffrey J. Easler
    Evan L. Fogel
    [J]. Digestive Diseases and Sciences, 2024, 69 : 1880 - 1888
  • [37] Post-ERCP multiple bleeding and related treatment in a decompensated cirrhotic patient with choledocholithiasis: a case report
    Zhou, Zhongcheng
    Chen, Jing
    Fei, Faming
    Wang, Jing
    Chen, Xujian
    Shen, Yiyu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8699 - 8703
  • [38] Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang Ha
    Eum, Jae Sup
    Lee, Sun Mi
    Song, Geun Am
    Kim, Dong Uk
    Kim, Il Doo
    Cho, Mong
    [J]. GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) : E11 - E18
  • [39] Does insertion of metallic biliary stent increase post-ERCP complications?
    Lin, S-Z
    Chen, C-C
    Lin, H-C
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A103 - A103
  • [40] Incidence rates of post-ERCP complications: A systematic survey of prospective studies
    Andriulli, Angelo
    Loperfido, Silvano
    Napolitano, Grazia
    Niro, Grazia
    Valvano, Maria Rosa
    Spirito, Fulvio
    Pilotto, Alberto
    Forlano, Rosario
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08): : 1781 - 1788